RecruitingNCT07197138
Two accelerated TMS schedules for depression after COVID
About this title
Read the official source — NCT07197138Device studyAges 18–65Germany
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
Participants are randomly assigned to one of two schedules, both with 30 active iTBS sessions. One schedule gives one session each weekday over six weeks; the other gives six sessions about an hour apart on five consecutive days. Each stimulation session lasts about three minutes.
- Listed locations
- MunichSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 11, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 42
- Sponsor
- Max-Planck-Institute of Psychiatry
- Sponsor type
- Research institute
- Study type
- Device
- Intervention type
- Device
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07197138
- Official title
Show the full official title
Pilot Study on the Effects of Intensified Repetitive Transcranial Magnetic Stimulation on Immunological Blood Parameters in Patients With Depression and Comorbid Post-COVID-19 Condition
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Munich
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Max-Planck-Institute of Psychiatry, a research institute.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
